What is it about?
In our practice, we noticed an increased prevalence but more specific pharmacogenetic studies are needed.
Featured Image
Why is it important?
The importance is that once we identify that population on time, we can do preventive medicine and promote health insurance and public health policies that cover MTHFR mutation-related diseases.
Perspectives
We can create support groups and do more studies.
Raul Morales-Borges
Read the Original
This page is a summary of: Need for pharmacogenetic studies on the prevalence of MTHFR mutations in Puerto Ricans and Hispanics, Drug Metabolism and Personalized Therapy, January 2017, De Gruyter,
DOI: 10.1515/dmpt-2017-0010.
You can read the full text:
Contributors
The following have contributed to this page
